Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. J. Fita · SciRah

Researcher profile · Semantic Scholar

M. J. Fita

Share profile

M. J. Fita — researcher profile on SciRah

h-index: 5
Works: 25
Citations: 94

Most-cited papers

Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence
Inmaculada de Juan Jiménez, Z. G. Casado, S. P. Suela, E. E. Cardeñosa +12 more
2013Familial Cancer29 citations
Semantic Scholar
PREPL deficiency: delineation of the phenotype and development of a functional blood assay
L. Régal, Emma Mårtensson, I. Maystadt, N. Voermans +13 more
2017Genetics in Medicine24 citations Open access
Semantic Scholar
PREPL deficiency: delineation of the phenotype and development of a functional blood assay (S46.008)
Luc Régal, Emma Mårtensson, I. Maystadt, N. Voermans +13 more
2017Neurology11 citations
Semantic Scholar
Advanced systemic amyloidosis secondary to metastatic renal cell carcinoma
M. Algarra, M. J. Fita, S. Sandiego, Héctor Aguilar +8 more
2020ecancermedicalscience9 citations Open access
Semantic Scholar
Newborn screening for homocystinurias: Recent recommendations versus current practice
R. Keller, P. Chrastina, M. Pavlíková, S. Gouveia +51 more
2018Journal of Inherited Metabolic Disease7 citations Open access
Semantic Scholar
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.
Francesco Massari, M. Rosellini, B. Melichar, E. Grande +29 more
2025JCO Global Oncology6 citations Open access
Semantic Scholar
Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first‐line anti‐programmed death‐1 monotherapy: A real‐world multicentre observational cohort study
S. Ochenduszko, J. García Sánchez, M. J. Fita, I. González-Barrallo +17 more
2023Pigment Cell & Melanoma Research4 citations
Semantic Scholar
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy--A Spanish Oncologic Genitourinary Group (SOGUG) study.
J. A. Arija, X. D. del Muro, B. Pérez-Valderrama, S. Vázquez Estévez +16 more
20152 citations
Semantic Scholar
Association of CTC detection by AdnaTest with outcome on enzalutamide in chemotherapy-naïve castration-resistant prostate cancer: Exploratory results from PREMIERE—A SOGUG trial.
A. Pous, S. Vázquez Estévez, A. G. del Alba, B. Mellado +16 more
20171 citations
Semantic Scholar
Impact of previous abiraterone acetate treatment in docetaxel safety profile: Preliminary results of the randomized phase II ABIDO-SOGUG trial.
I. Durán, M. Climent, A. Font, M. Sáez +16 more
20161 citations
Semantic Scholar
Locoregional relapse in BRCA1/2 breast cancer women treated with breast-conserving surgery.
M. J. Fita, I. Chirivella, A. Sánchez, C. Salvador +11 more
20161 citations
Semantic Scholar
Comparison of stem cell signaling pathways in long-term responders (LR) versus primary refractory (PR) patients with metastatic clear-cell renal cell carcinoma (ccRCC) under sunitinib (SU) treatment (SULONG study).
J. Puente, N. Laínez, M. Méndez-Vidal, E. Esteban +15 more
20141 citations
Semantic Scholar
Real-World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON-3 Study.
L. Incorvaia, V. Mollica, O. Fiala, Kazutoshi Fujita +34 more
2026The Prostate0 citations Open access
Semantic Scholar
A0296 Real-world incidence and clinical impact of grade 3–4 adverse events in patients with metastatic renal cell carcinoma treated with first-line immune combinations: ARON-1 study
B. Maiorano, P. Valdez-Sandoval, S. Scagliarini, E. L. Beas-Lozano +16 more
2026European Urology0 citations
Semantic Scholar
Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.
P. Rescigno, T. Taha, M. J. Fita, Diana Matthews +40 more
2026Minerva urology and nephrology0 citations
Semantic Scholar
Global disparities in the availability and reimbursement of systemic therapies for renal cell carcinoma: results of the International ARON-AID Survey
Y. Ürün, K. Sridharan, A. Zgura, A. Zayed +138 more
2026The Oncologist0 citations Open access
Semantic Scholar
Recognition and management of organ-specific toxicities associated with enfortumab vedotin plus pembrolizumab and erdafitinib in locally advanced or metastatic urothelial carcinoma
M. J. Fita, U. Anido, Luis Bataller, G. de Velasco +4 more
2026Cancer Treatment Reviews0 citations
Semantic Scholar
Integrated analysis of mRNA and miRNA to unravel novel mechanisms of sunitinib long term response in mRCC.
J. Puente, N. Laínez, M. Dueñas, M. Méndez-Vidal +16 more
20160 citations
Semantic Scholar
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study.
B. Pérez-Valderrama, J. A. Arija, P. Borrega, Á. Sánchez +16 more
20150 citations
Semantic Scholar
Mammographic density and breast cancer in women from high risk families
M. Pollán, I. Chirivella, J. Miranda, À. Teulé +16 more
2014Breast Cancer Research0 citations Open access
Semantic Scholar
Cáncer de próstata en el anciano
M. A. Durán, M. J. Fita, M. Chilet
20140 citations
Semantic Scholar
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).
L. L. Mateos, L. Muinelo, B. Pérez-Valderrama, B. Mellado +12 more
20140 citations
Semantic Scholar
Beyond genetics: Cancer and environmental factors
V. Guillem-Porta, M. J. Fita
20130 citations Open access
Semantic Scholar
Más allá de la genética: factores ambientales y cáncer
V. G. Porta, M. J. Fita
20130 citations
Semantic Scholar
Familial breast cancer in Spain: A retrospective study of family history and clinical/pathologic characteristics from the GEICAM “El Álamo III” project.
I. Márquez-Rodas, M. Pollán, A. Lluch, T. R. Y. Cajal +16 more
20130 citations
Semantic Scholar
Estudio comparativo de las acciones de diazepam y otros inhibidores de fosfodiesterasa sobre los efectos de dopamina, dobutamina y glucagón en miocardio de rata
M. J. Fita
20040 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Pérez-Valderrama×7
Invite
B. Pérez-Valderrama — researcher profile on SciRah
D. Castellano×6
Invite
D. Castellano — researcher profile on SciRah
O. Fiala×4
Invite
O. Fiala — researcher profile on SciRah
J. Molina-Cerrillo×4
Invite
J. Molina-Cerrillo — researcher profile on SciRah

×4

Invite

Andrey Soares — researcher profile on SciRah

Invite

Y. Ürün — researcher profile on SciRah

Invite

M. Santoni — researcher profile on SciRah

Invite

J. A. Arija — researcher profile on SciRah

S. Vázquez Estévez×4

Invite

S. Vázquez Estévez — researcher profile on SciRah

Invite

P. Maroto — researcher profile on SciRah

M. Méndez-Vidal×4

Invite

M. Méndez-Vidal — researcher profile on SciRah

A. G. del Alba×4

Invite

A. G. del Alba — researcher profile on SciRah